asandeutertinib   Click here for help

GtoPdb Ligand ID: 13201

Synonyms: Embodiment 3A [US10414756]
Compound class: Synthetic organic
Comment: Asandeutertinib is the INN for an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antineoplastic potential. It is one of the structures (3A) claimed in Nanjing Diansu Biological Technology's patent US10414756B2 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 84.8
Molecular weight 499.61
XLogP 1.89
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CC(=O)NC1=C(C=C(C(=C1)NC2=NC=CC(=N2)C3=CN(C([2H])([2H])[2H])C4=C3C=CC=C4)OC)N(C)CCN(C)C
Isomeric SMILES [2H]C([2H])([2H])N1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
InChI InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)/i5D3
InChI Key DUYJMQONPNNFPI-VPYROQPTSA-N
References
1. Zhu X, Jiang M, Ji A. (2019)
2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof.
Patent number: US10414756B2. Assignee: Nanjing Diansu Biological Technology Co Ltd. Priority date: 31/07/2015. Publication date: 17/09/2019.